Investigación / Grupos de investigación

Grupo  301

Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Publicaciones (907)

  • Pignon, B; Lajnef, M; Kirkbride, JB; Peyre, H; Ferchiou, A; Richard, JR; Baudin, G; Tosato, S; Jongsma, H; de Haan, L; Tarricone, I; Bernardo, M; Velthorst, E; Braca, M; Arango, C; Arrojo, M; Bobes, J; Del-Ben, CM; Di Forti, M; Gayer-Anderson, C; Jones, PB; La Cascia, C; Lasalvia, A; Menezes, PR; Quattrone, D; Sanjuan, J; Selten, JP; Tortelli, A; Llorca, PM; van Os, J; Rutten, BPF; Murray, RM; Morgan, C; Leboyer, M; Szoke, A; Schurhoff, F.

    The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings From the Multinational EU-GEI Study

    SCHIZOPHRENIA BULLETIN. 2021; 47(6): 1674-1684 Nº de citas: 24 [doi:10.1093/schbul/sbab060]

  • Marques-Feixa, L; Moya-Higueras, J; Romero, S; Santamarina-Perez, P; Rapado-Castro, M; Zorrilla, I; Martin, M; Anglada, E; Lobato, MJ; Ramirez, M; Moreno, N; Mayoral, M; Marin-Vila, M; Arias, B; Fananas, L.

    Risk of Suicidal Behavior in Children and Adolescents Exposed to Maltreatment: The Mediating Role of Borderline Personality Traits and Recent Stressful Life Events

    Journal of Clinical Medicine. 2021; 10(22): Nº de citas: 16 [doi:10.3390/jcm10225293]

  • Gonzalez, MM; Hualpa, JCP; Moreno, DM; Albarran, OG.

    A case of type 1 diabetes mellitus in a woman with Shwachman-Diamond syndrome

    Practical Diabetes. 2021; 38(6): 41-43 Nº de citas: 1 [doi:10.1002/pdi.2370]

  • de Pablo, GS; Solmi, M; Vaquerizo-Serrano, J; Radua, J; Passina, A; Mosillo, P; Correll, CU; Borgwardt, S; Galderisi, S; Bechdolf, A; Pfennig, A; Bauer, M; Kessing, LV; van Amelsvoort, T; Nieman, DH; Domschke, K; Krebs, MO; Sand, M; Vieta, E; McGuire, P; Arango, C; Il Shin, J; Fusar-Poli, P.

    Primary prevention of depression: An umbrella review of controlled interventions

    JOURNAL OF AFFECTIVE DISORDERS. 2021; 294: 957-970 Nº de citas: 35 [doi:10.1016/j.jad.2021.07.101]

  • Marin-Navarrete, R; Torrens, M; Toledo-Fernandez, A; Mestre-Pinto, JI; Sanchez-Dominguez, R; Perez-Lopez, A; Saracco-Alvarez, R; Madrigal-De Leon, EA; Szerman, N.

    Developing an App to Screen for Dual Disorders: A Tool for Improving Treatment Services in Mexico

    Frontiers in Psychiatry. 2021; 12: 697598-697598 Nº de citas: 1 [doi:10.3389/fpsyt.2021.697598]

  • Gasso, P; Rodriguez, N; Martinez-Pinteno, A; Mezquida, G; Ribeiro, M; Gonzalez-Penas, J; Zorrilla, I; Martinez-Sadurni, L; Rodriguez-Jimenez, R; Corripio, I; Sarro, S; Ibanez, A; Usall, J; Lobo, A; Moren, C; Cuesta, MJ; Parellada, M; Gonzalez-Pinto, A; Berrocoso, E; Bernardo, M; Mas, S; 2EPs Grp.

    A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood

    Translational Psychiatry. 2021; 11(1): 539-539 Nº de citas: 8 [doi:10.1038/s41398-021-01645-8]

  • Gonzalez-Blanco, L; Garcia-Portilla, MP; Gutierrez, M; Mezquida, G; Cuesta, MJ; Urbiola, E; Amoretti, S; Barcones, F; Gonzalez-Pinto, A; Pina-Camacho, L; Corripio, I; Vieta, E; Baeza, I; Toll, A; Saiz, PA; Bobes, J; Bernardo, M; PEPs Grp.

    Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research. 2021; 236: 19-28 Nº de citas: 11 [doi:10.1016/j.schres.2021.07.017]

  • Ferraro, L; La Cascia, C; La Barbera, D; Sanchez-Gutierrez, T; Tripoli, G; Seminerio, F; Sartorio, C; Marrazzo, G; Sideli, L; Arango, C; Arrojo, M; Bernardo, M; Bobes, J; Del-Ben, CM; Gayer-Anderson, C; Jongsma, HE; Kirkbride, JB; Lasalvia, A; Tosato, S; Llorca, PM; Menezes, PR; Rutten, BP; Santos, JL; Sanjuan, J; Selten, JP; Szoke, A; Tarricone, I; Muratori, R; Tortelli, A; Velthorst, E; Rodriguez, V; Quattrone, A; Jones, PB; Van Os, J; Vassos, E; Morgan, C; de Haan, L; Reininghaus, U; Cardno, AG; Di Forti, M; Murray, RM; Quattrone, D.

    The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study

    Schizophrenia Research. 2021; 236: 69-79 Nº de citas: 12 [doi:10.1016/j.schres.2021.08.008]

  • Arango, C; Dragioti, E; Solmi, M; Cortese, S; Domschke, K; Murray, RM; Jones, PB; Uher, R; Carvalho, AF; Reichenberg, A; Shin, JI; Andreassen, OA; Correll, CU; Fusar-Poli, P.

    Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas

    World Psychiatry. 2021; 20(3): 417-436 Nº de citas: 229 [doi:10.1002/wps.20894]

  • Canal-Rivero, M; Ayesa-Arriola, R; Setien-Suero, E; Crespo-Facorro, B; Arango, C; Dutta, R; Lopez-Morinigo, JD.

    Understanding the Influence of Personality Traits on Risk of Suicidal Behaviour in Schizophrenia Spectrum Disorders: A Systematic Review

    Journal of Clinical Medicine. 2021; 10(19): Nº de citas: 3 [doi:10.3390/jcm10194604]

  • Valencia, F; Penelo, E; de la Osa, N; Navarro, JB; Ezpeleta, L.

    Prospective association of parental and child internalizing symptoms: Mediation of parenting practices and irritability

    BRITISH JOURNAL OF DEVELOPMENTAL PSYCHOLOGY. 2021; 39(3): 363-379 Nº de citas: 3 [doi:10.1111/bjdp.12367]

  • Sami, M; Quattrone, D; Ferraro, L; Tripoli, G; La Cascia, E; Gayer-Anderson, C; Selten, JP; Arango, C; Bernardo, M; Tarricone, I; Tortelli, A; Gatto, G; del Peschio, S; Del-Ben, CM; Rutten, BP; Jones, PB; van Os, J; de Haan, L; Morgan, C; Lewis, C; Bhattacharyya, S; Freeman, TP; Lynskey, M; Murray, RM; Di Forti, M.

    Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls

    PSYCHOLOGICAL MEDICINE. 2021; 51(12): 2074-2082 Nº de citas: 8 [doi:10.1017/S0033291720000847]

  • Ballesteros, A; Torres, AMS; Lopez-Ilundain, J; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Pina-Camacho, L; Corripio, I; Vieta, E; de la Serna, E; Mane, A; Bioque, M; Moreno-Izco, L; Espliego, A; Lorente-Omenaca, R; Amoretti, S; Bernardo, M; Cuesta, MJ; PEPs Grp.

    The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory

    PSYCHOLOGICAL MEDICINE. 2021; 51(12): 2044-2053 Nº de citas: 7 [doi:10.1017/S003329172000080X]

  • Rapado-Castro, M; Villar-Arenzana, M; Janssen, J; Fraguas, D; Bombin, I; Castro-Fornieles, J; Mayoral, M; Gonzalez-Pinto, A; de la Serna, E; Parellada, M; Moreno, D; Paya, B; Graell, M; Baeza, I; Pantelis, C; Arango, C.

    Fronto-Parietal Gray Matter Volume Loss Is Associated with Decreased Working Memory Performance in Adolescents with a First Episode of Psychosis

    Journal of Clinical Medicine. 2021; 10(17): Nº de citas: 10 [doi:10.3390/jcm10173929]

  • Persico, AM; Ricciardello, A; Lamberti, M; Turriziani, L; Cucinotta, F; Brogna, C; Vitiello, B; Arango, C.

    The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present

    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2021; 110: 110326-110326 Nº de citas: 85 [doi:10.1016/j.pnpbp.2021.110326]

  • Parellada, M; Caceres, ASJ; Palmer, M; Delorme, R; Jones, EJH; Parr, JR; Anagnostou, E; Murphy, DGM; Loth, E; Wang, PP; Charman, T; Strydom, A; Arango, C; AIMS-2-TRIALS-CT1 Grp.

    A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1

    Frontiers in Psychiatry. 2021; 12: 701729-701729 Nº de citas: 14 [doi:10.3389/fpsyt.2021.701729]

  • Panchal, U; de Pablo, GS; Franco, M; Moreno, C; Parellada, M; Arango, C; Fusar-Poli, P.

    The impact of COVID-19 lockdown on child and adolescent mental health: systematic review

    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021; 32(7): 1-27 Nº de citas: 767 [doi:10.1007/s00787-021-01856-w]

  • Martinez-Pinteno, A; Gasso, P; Prohens, L; Segura, AG; Parellada, M; Saiz-Ruiz, J; Cuesta, MJ; Bernardo, M; Lafuente, A; Mas, S; Rodriguez, N.

    Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data

    Frontiers in Pharmacology. 2021; 12: 729474-729474 Nº de citas: 5 [doi:10.3389/fphar.2021.729474]